Sort by
VLEO Satellite Development and Remote Sensing: A Multidomain Review of Engineering, Commercial and Regulatory Solutions
Ramson Nyamukondinawa
,Walter Peeters
,Sradha Udayakumar
Posted: 18 December 2025
Urban Green Space Per Capita for Sustainable and Equitable Urban Planning: A Systematic Review and Bibliometric Analysis
Yaseen N. Hassan
,Sándor Jombach
Posted: 18 December 2025
Effect of Salinity on Photosynthetic Performance in Cup Plant (Silphium Perfoliatum L.)
Marta Jańczak-Pieniążek
,Mateusz Koszorek
,Karol Skrobacz
,Dagmara Migut
Posted: 18 December 2025
Patterns of Inflammation in Experimental Autoimmune Uveitis and Their Correlation to Optical Coherence Tomography Findings in Human Uveitis
Benedikt Schworm
,Tarek Ghannoum
,Stephan Thurau
,Gerhild Wildner
Posted: 18 December 2025
Use of Polyhexanide-Poloxamer for Intraoperative Surgical Wound Irrigation in Orthopedics: An Italian Delphi Consensus
Pier Francesco Indelli
,Massimiliano De Paolis
,Arcangelo Russo
,Massimo Fantoni
,Augusto Palermo
,Giovanni Pomponio
,Alessandro Scalise
,Domenico Tigani
,Bruno Violante
,Steven Percival
+2 authors
Introduction: Surgical site infections (SSIs) and prosthetic joint infections (PJIs) remain among the most serious complications in orthopedic surgery, and chemical debridement is recommended for all septic revisions. The combination of polyhexanide (PHMB) and poloxamer (PLX), with in vitro antimicrobial and antibiofilm activity, represents a promising antiseptic solution. A Delphi consensus to define the indications and clinical applications of PHMB/PLX as an antiseptic solution was carried out. Materials and methods: A steering committee convened a panel of orthopedic surgeons, infectious disease specialists, and wound care specialists with expertise in musculoskeletal infections. A three-phase Delphi process was conducted. Twelve clinical questions and four outcome measures were developed through literature review and iterative discussion. Two Delphi rounds were conducted using a 9-point Likert scale, and statements were rated according to the GRADE method. Results: All 12 final statements achieved strong agreement. The panel identified key patient-related risk factors (smoking, diabetes, obesity, immunosuppression) and procedure-related risks (open fractures, primary/revision arthroplasty, prolonged operative time). Antiseptic irrigation was considered superior to saline, and PHMB-PLX was seen as a helpful addition to mechanical debridement given its antibiofilm activity and good cytocompatibility. Low-pressure irrigation and short exposure times are the preferred application methods, while avoiding use on cartilage or neural tissues. Conclusions: The Delphi panel reached a strong consensus supporting the intraoperative use of PHMB-PLX as a safe and effective antiseptic adjunct for preventing and treating SSIs in orthopedic surgery. The panel recommended conducting high-quality clinical research to verify these findings and improve standardized irrigation protocols.
Introduction: Surgical site infections (SSIs) and prosthetic joint infections (PJIs) remain among the most serious complications in orthopedic surgery, and chemical debridement is recommended for all septic revisions. The combination of polyhexanide (PHMB) and poloxamer (PLX), with in vitro antimicrobial and antibiofilm activity, represents a promising antiseptic solution. A Delphi consensus to define the indications and clinical applications of PHMB/PLX as an antiseptic solution was carried out. Materials and methods: A steering committee convened a panel of orthopedic surgeons, infectious disease specialists, and wound care specialists with expertise in musculoskeletal infections. A three-phase Delphi process was conducted. Twelve clinical questions and four outcome measures were developed through literature review and iterative discussion. Two Delphi rounds were conducted using a 9-point Likert scale, and statements were rated according to the GRADE method. Results: All 12 final statements achieved strong agreement. The panel identified key patient-related risk factors (smoking, diabetes, obesity, immunosuppression) and procedure-related risks (open fractures, primary/revision arthroplasty, prolonged operative time). Antiseptic irrigation was considered superior to saline, and PHMB-PLX was seen as a helpful addition to mechanical debridement given its antibiofilm activity and good cytocompatibility. Low-pressure irrigation and short exposure times are the preferred application methods, while avoiding use on cartilage or neural tissues. Conclusions: The Delphi panel reached a strong consensus supporting the intraoperative use of PHMB-PLX as a safe and effective antiseptic adjunct for preventing and treating SSIs in orthopedic surgery. The panel recommended conducting high-quality clinical research to verify these findings and improve standardized irrigation protocols.
Posted: 18 December 2025
Effectiveness of the Temporal Flap in Reconstruction After Advanced External Ear Tumor Resection: A Case Report
Kostadin Gigov
,Petra Kavradzhieva
,Ivan Ginev
,Mihaela Bogdanova
Posted: 18 December 2025
The Unseen Tension: A Narrative Review of Long-Term Outcomes of Social Anxiety Disorder
Priyal Khurana
,Aditya Sharma
,Mayank Gupta
Posted: 18 December 2025
Lymphoscintigraphy as Part of Nuclear Medicine of the Third Millennium
Lucio Mango
Posted: 18 December 2025
Psychometric Evaluation of the Motivators and Resources for Trauma Recovery (I-MOVE) Scale among Gender-Based Violence Survivors
Farida Bibi Mughal
,Laura Sinko
,Sachiko Kita
,Lisa Fedina
,Denise Saint Arnault
Posted: 18 December 2025
SORT-AI: A Projection-Based Structural Framework for AI Safety Alignment Stability, Drift Detection, and Scalable Oversight
Gregor Herbert Wegener
Posted: 18 December 2025
Dynamics of Information Quantifiers in the Damped Rabi Oscillator
F. Pennini
,A. Plastino
Posted: 18 December 2025
Once-Monthly Incretin-, Amylin-, and THRβ-Targeting Therapies for Type 2 Diabetes and Obesity: Clinical Evidence and Development Pipelines
Héctor Iván Saldívar-Cerón
Once-monthly injectable therapies targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and adjacent metabolic pathways are moving from a conceptual goal to a plausible next step for type 2 diabetes (T2D) and obesity. The most clinically advanced program is maridebart cafraglutide (MariTide), a long-acting GLP-1 receptor agonist conjugated to an Fc-containing scaffold that also mediates sustained GIP receptor antagonism. Across phase 2 trials, once-monthly maridebart has produced clinically meaningful weight loss (~12–16% in adults without diabetes; ~8–12% in those with T2D) together with HbA1c reductions of ~1.2–1.6 percentage points, with a safety profile broadly consistent with GLP-1–based therapy. An exploratory every-8-weeks regimen showed attenuated efficacy, suggesting that monthly dosing may represent a practical lower boundary for maintaining therapeutic exposure and metabolic effect in this format. Beyond maridebart, a rapidly expanding pipeline—including ultra–long-acting GLP-1 analogues, dual GLP-1/GIP agonists, long-acting GIPR antagonists, amylin receptor agonists, and emerging thyroid hormone receptor beta (THRβ) agonists—is actively testing monthly regimens or induction-to-monthly maintenance strategies; however, most readouts remain early and are frequently limited to conference presentations or sponsor communications. Key uncertainties include long-term durability, cardiometabolic outcomes, immunogenicity, and interindividual variability in response, which will ultimately determine how once-monthly regimens integrate with established weekly standards in routine care.
Once-monthly injectable therapies targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and adjacent metabolic pathways are moving from a conceptual goal to a plausible next step for type 2 diabetes (T2D) and obesity. The most clinically advanced program is maridebart cafraglutide (MariTide), a long-acting GLP-1 receptor agonist conjugated to an Fc-containing scaffold that also mediates sustained GIP receptor antagonism. Across phase 2 trials, once-monthly maridebart has produced clinically meaningful weight loss (~12–16% in adults without diabetes; ~8–12% in those with T2D) together with HbA1c reductions of ~1.2–1.6 percentage points, with a safety profile broadly consistent with GLP-1–based therapy. An exploratory every-8-weeks regimen showed attenuated efficacy, suggesting that monthly dosing may represent a practical lower boundary for maintaining therapeutic exposure and metabolic effect in this format. Beyond maridebart, a rapidly expanding pipeline—including ultra–long-acting GLP-1 analogues, dual GLP-1/GIP agonists, long-acting GIPR antagonists, amylin receptor agonists, and emerging thyroid hormone receptor beta (THRβ) agonists—is actively testing monthly regimens or induction-to-monthly maintenance strategies; however, most readouts remain early and are frequently limited to conference presentations or sponsor communications. Key uncertainties include long-term durability, cardiometabolic outcomes, immunogenicity, and interindividual variability in response, which will ultimately determine how once-monthly regimens integrate with established weekly standards in routine care.
Posted: 18 December 2025
NKG2D-Based CAR-T Cells for Cancer Immunotherapy: Biological Rationale, Clinical Experience, and Current Challenges
Vitaly Chasov
,Albert Rizvanov
Posted: 18 December 2025
Capital‑Light Entrepreneurship in Rwanda: A Scoping Review of Low-Capital Business Opportunities
Sixbert Sangwa
,Sylvie Ndahimana
,Placide Mutabazi
Purpose: This study interrogates Rwanda’s persistent finance gap by systematically identifying business models that tertiary-educated youth and professionals can launch with negligible start-up cash. It clarifies which “business-with-no-capital” slogans hold empirical merit and how such ventures contribute to inclusive growth. Design/Methodology/Approach: A PRISMA-guided scoping review of 40 academic, policy and grey sources (2015–2025) mapped low-capital opportunities across all economic sectors. Each model was appraised through an Evidence-Weighted Feasibility Scoring framework covering regulatory complexity, skills intensity, time-to-first-revenue, market access, scalability and community value, yielding an integrative Feasibility Matrix. Findings: Analysis reveals a diversified Capital-Light Opportunity Architecture in Rwanda. Highest-feasibility pathways cluster in (i) digital freelancing and micro-consulting, (ii) commission-based agency and dropship commerce, and (iii) agribusiness brokerage and clean-energy micro-distribution. These ventures generate revenue within days to weeks, demand modest upskilling rather than credit, and, when scaled, enhance financial inclusion, food systems efficiency and environmental health. Nonetheless, feasibility is sector-contingent: digital options scale fastest but require strong human capital, whereas agribusiness delivers deeper community impact at slower payback. Practical and Social Implications: The study offers policymakers an actionable Feasibility Matrix, risk-guardrail table and Impact Assessment Framework to inform streamlined formalisation, youth-targeted micro-grants, shared-asset hubs and anti-predatory market surveillance. Educators and incubators can embed the scoring tool to steer graduates toward evidence-backed, capital-light start-ups instead of speculative schemes. Originality/Value: By synthesising dispersed evidence into a transparent scoring rubric, the paper pioneers a rigorous yet practitioner-ready lens on ultra-lean entrepreneurship in low-income economies. It moves the discourse from inspirational anecdotes to data-driven guidance, aligning with Rwanda’s vision of a knowledge-based, job-creating economy.
Purpose: This study interrogates Rwanda’s persistent finance gap by systematically identifying business models that tertiary-educated youth and professionals can launch with negligible start-up cash. It clarifies which “business-with-no-capital” slogans hold empirical merit and how such ventures contribute to inclusive growth. Design/Methodology/Approach: A PRISMA-guided scoping review of 40 academic, policy and grey sources (2015–2025) mapped low-capital opportunities across all economic sectors. Each model was appraised through an Evidence-Weighted Feasibility Scoring framework covering regulatory complexity, skills intensity, time-to-first-revenue, market access, scalability and community value, yielding an integrative Feasibility Matrix. Findings: Analysis reveals a diversified Capital-Light Opportunity Architecture in Rwanda. Highest-feasibility pathways cluster in (i) digital freelancing and micro-consulting, (ii) commission-based agency and dropship commerce, and (iii) agribusiness brokerage and clean-energy micro-distribution. These ventures generate revenue within days to weeks, demand modest upskilling rather than credit, and, when scaled, enhance financial inclusion, food systems efficiency and environmental health. Nonetheless, feasibility is sector-contingent: digital options scale fastest but require strong human capital, whereas agribusiness delivers deeper community impact at slower payback. Practical and Social Implications: The study offers policymakers an actionable Feasibility Matrix, risk-guardrail table and Impact Assessment Framework to inform streamlined formalisation, youth-targeted micro-grants, shared-asset hubs and anti-predatory market surveillance. Educators and incubators can embed the scoring tool to steer graduates toward evidence-backed, capital-light start-ups instead of speculative schemes. Originality/Value: By synthesising dispersed evidence into a transparent scoring rubric, the paper pioneers a rigorous yet practitioner-ready lens on ultra-lean entrepreneurship in low-income economies. It moves the discourse from inspirational anecdotes to data-driven guidance, aligning with Rwanda’s vision of a knowledge-based, job-creating economy.
Posted: 18 December 2025
Correct Degree Selection for Koopman Mode Decomposition
Kilho Shin
,Shodai Asaoka
Posted: 18 December 2025
Global-Local-Structure Collaborative Approach for Cross-Domain Reference-Based Image Super-Resolution
Xiuxia Cai
,Chenyang Diwu
,Ting Fan
,Wenjing Wang
,Jinglu He
Posted: 18 December 2025
Adaptive Bandelet Transform and Transfer Learning for Geometry‑Aware Thyroid Cancer Ultrasound Classification
Yassine Habchi
,Hamza Kheddar
,Mohamed Chahine Ghanem
,Jamal Hwaidi
Posted: 18 December 2025
Adaptive Contextual Feature Grafting and Hierarchical Structure-Aware Initialization for Training-Free Subject-Driven Text-to-Image Generation
Salma Ali
,Noah Fang
Posted: 18 December 2025
Quantum Relativity (Electron Ripple)
Ahmed Mohamed Ismail
,Samira Ezzat Mohamed
Posted: 18 December 2025
Efficacy and Limitations of an Improved Vaccine Derived from an Updated Vaccine Strain Against H5 High Pathogenicity Avian Influenza
Bao Linh Nguyen
,Norikazu Isoda
,Yik Lim Hew
,Loc Tan Huynh
,Kien Trung Le
,Yo Shimazu
,Daiki Kobayashi
,Dang Hoang Nguyen
,Duc-Huy Chu
,Diep Thi Nguyen
+2 authors
Posted: 18 December 2025
of 5,350